Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

885 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial

NCT00035815

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Mayo Clinic in Scottsdale Scottsdale, Arizona, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Clinic in Jacksonville Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 20 locations
View Trial Details
Completed

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Mayo Clinic, Scottsdale Scottsdale, Arizona, United States
  • UC, Irvine Irvine, California, United States
  • UCLA Los Angeles, California, United States
  • California Pacific Med Center Forbes Norris MDA/ALS Research and Treatment Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT00748501

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Coordinated Clinical Research La Jolla, California, United States
  • University of California, Irvine; MDA ALS and Neuromuscular Center, Orange, California, United States
  • California Pacific Medical Center (CPMC), The Forbes Norris MDA/ALS Research Center San Francisco, California, United States
  • The University of Kansas Medical Center (KU) Kansas City, Kansas, United States
View Trial Details

Related conditions